Description

The global botulinum toxin market is poised to grow by US$ 3.4 billion from 2022 to 2028, registering a CAGR of 7.8% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for botulinum toxin. The global botulinum toxin market is segmented on the basis of product, application, end user, and region. By product, the global botulinum toxin market has been segmented into type A botulinum toxin, type B botulinum toxin. Based upon application, the global botulinum toxin market is categorized into aesthetic, medical. On the basis of end user, the global botulinum toxin market has been segmented into hospitals, specialty and dermatology clinics, others. In terms of geography, the global botulinum toxin market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The aesthetic application market is further segmented into forehead lines, glabellar lines, lateral canthal lines (crow’s feet), and others. Furthermore, the medical application market has been categorized into chronic migraine, hyperhidrosis, muscle spasm, over reactive bladder, and others.

The global botulinum toxin market is highly competitive. Some of the leading companies operating in the market are AbbVie Inc. (Allergan plc), Daewoong Pharmaceutical Co. Ltd., Evolus Inc., Galderma S.A., HUGEL Inc., Ipsen S.A., Lanzhou Institute of Biological Products Co. Ltd., Medy-Tox Inc., Merz Pharma GmbH & Co. KGaA, Revance Therapeutics Inc., US WorldMeds LLC.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the botulinum toxin market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: type A botulinum toxin, type B botulinum toxin
Application: aesthetic, medical
End user: hospitals, specialty and dermatology clinics, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global botulinum toxin market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Botulinum toxin market overview
Part 3. Market breakdown by product
– Type A botulinum toxin
– Type B botulinum toxin
Part 4. Market breakdown by application
– Aesthetic
– Medical
Part 5. Market breakdown by end user
– Hospitals
– Specialty and dermatology clinics
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– AbbVie Inc. (Allergan plc)
– Daewoong Pharmaceutical Co., Ltd.
– Evolus Inc.
– Galderma S.A.
– HUGEL Inc.
– Ipsen S.A.
– Lanzhou Institute of Biological Products Co., Ltd.
– Medy-Tox Inc.
– Merz Pharma GmbH & Co. KGaA
– Revance Therapeutics Inc.
– US WorldMeds LLC
About StrategyHelix
Disclaimer